Upregulation of IRAS/nischarin (I1-imidazoline receptor), a regulatory protein of μ-opioid receptor trafficking, in postmortem prefrontal cortex of long-term opiate and mixed opiate/cocaine abusers

Imidazoline receptor antisera-selected (IRAS)/nischarin, a putative I-1-imidazoline receptor, has recently been shown to regulate mu-opioid receptor (OR) trafficking and resensitisation. To study a possible involvement of this mu-OR regulator in opiate dependence, the present study assessed by Western blot analysis the contents of IRAS/nischarin and mu-OR in total homogenates and subcellular preparations of postmortem human prefrontal cortex (PFC/BA9) of long-term opiate and mixed opiate/cocaine abusers as well as of matched healthy control subjects. In the PFC/BA9 of long-term opiate/cocaine abusers (all subjects together) IRAS/nischarin content was increased (+67%, p < 0.01, n = 11) when compared with matched controls (n = 10). Similar increases were found for the subgroups of opiate (+72%, n = 6) and mixed opiate/cocaine (+61%, n = 5) abusers. IRAS/nischarin immunocontents were also found increased in subcellular membrane preparations (+61%, p < 0.05, n = 10) of PFC/BA9 from opiate addicts. In the same brain samples, the levels of mu-OR were not different to those in control subjects. Based on the increased contents in brains of opiate abusers and the reported function as mu-OR regulator, IRAS/nischarin could represent a new promising target for treatment of opiate use disorder. (C) 2017 Elsevier Ltd. All rights reserved.